The QualityStocks Daily Monday, November 14th, 2022

Today's Top 3 Investment Newsletters

SmallCapRelations(FRGT) $0.4410 +113.15%

QualityStocks(OPNT) $20.1000 +111.58%

Stocks to Buy Now(SYTA) $0.1650 +26.92%

The QualityStocks Daily Stock List

ToughBuilt Industries (TBLT)

MarketClub Analysis, QualityStocks, BUYINS.NET, Broad Street, StockMarketWatch, MarketBeat, StocksEarning, PennyStockLocks, StockRockandRoll, MicroCapDaily, Penny Stock 101, BeatPennyStocks, OTCtipReporter, Penny Picks, AwesomeStocks, PennyStockScholar, Timothy Sykes, Profitable Trader Authority, Schaeffer's, StockOnion, StreetInsider, The Online Investor and PennyStockProphet reported earlier on ToughBuilt Industries (TBLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ToughBuilt Industries Inc. (NASDAQ: TBLT) (FRA: 36QA) is a firm that is engaged in the design, development, manufacture and distribution of home improvement and construction products for the building industry, both internationally as well as in the United States.

ToughBuilt Industries is a part of the hand tool, cutlery and flatware manufacturing industry and is based in Lake Forest, California. The firm was founded on April 9, 2012 by Joshua Keeler and Michael Panosian. Before changing its name in December 2015, ToughBuilt Industries Inc. was known as Phalanx Inc.

The company’s product line includes Sawhorses and work products, and Soft goods and kneepads. The majority of the firm’s revenue comes from the sale of soft good products while geographically, ToughBuilt Industries generates a major share of its revenue from the United States.

ToughBuilt Industries Inc. takes part in marketing and distributing home improvement and construction product lines under the TOUGHBUILT brand name, through different professional outlets, home improvement big box stores and wholesale/trade outlets. This is in addition to providing gloves, sawhorse/jobsite tables, roller stands, table saws, miter saws, sawhorses, kneepads, office organizers/bags for cellphones/tablets/laptops, different storage solutions, totes, tool bags, tool belts and accessories, tool rigs and tool pouches.

As of 2020, ToughBuilt Industries Inc. had expanded its distribution network in Mexico in an attempt to meet the demand in South America. This move will not only enhance the firm’s logistics capabilities but allow the ToughBuilt to venture into new areas, explore new opportunities and grow.

ToughBuilt Industries (TBLT), closed Monday's trading session at $3.79, up 72.2727%, on 76,905,713 volume. The average volume for the last 3 months is 1.86M and the stock's 52-week low/high is $1.34/$78.15.

Opiant Pharmaceuticals, Inc. (OPNT)

StockMarketWatch, BUYINS.NET, QualityStocks, StreetAuthority Daily, MarketBeat, TopStockAnalysts, ProfitableTrading, StreetInsider, Zacks, Hit and Run Candle Sticks, Schaeffer's, BestOtc, StocksEarning, TopPennyStockMovers, PoliticsAndMyPortfolio, Trade of the Week, TradersPro, FeedBlitz, Daily Markets, Wall Street Mover and SmarTrend Newsletters reported earlier on Opiant Pharmaceuticals, Inc. (OPNT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Santa Monica, California. It is developing pharmacological treatments for substance use, addictive, as well as eating disorders. Opiant Pharmaceuticals has its unique opioid antagonist nasal delivery technology. The Company’s initial product is NARCAN® Nasal Spray. It has approval for marketing in the U.S. by Opiant’s partner, Adapt Pharma Limited. Opiant Pharmaceuticals’ shares trade on the NasdaqCM.

The Company is developing opioid antagonists for the treatment of substance use, addictive and eating disorders, with a near term concentration on cocaine use disorder and binge eating disorder (BED). Regarding BED, Opiant Pharmaceuticals states that its opioid antagonist nasal spray could be used as a symptom-driven therapy to manage activation of the reward circuitry, and assist patients in controlling their bingeing behavior.

NARCAN® Nasal Spray is a prescription medicine used for the treatment of an opioid emergency. NARCAN® Nasal Spray is to be given immediately. However, it does not take the place of emergency medical care. Opiant Pharmaceuticals has an international, exclusive licensing agreement providing it access to Aegis’ Intravail® drug delivery technology for all of Opiant’s opioid antagonist compounds.

In November 2017, Opiant Pharmaceuticals and Titan Pharmaceuticals, Inc. (TTNP) announced a collaboration to investigate development of a novel approach to the prevention of opioid relapse and overdose in individuals with opioid use disorder. The two companies will conduct a feasibility assessment of a subcutaneous implant employing Titan Pharmaceuticals’ proprietary ProNeura™ sustained release technology to administer an opioid antagonist.

Opiant Pharmaceuticals, Inc. (OPNT), closed Monday's trading session at $20.1, up 111.5789%, on 1,860,156 volume. The average volume for the last 3 months is 297,978 and the stock's 52-week low/high is $7.34/$37.7114.

Gogoro Inc. (GGR)

SmarTrend Newsletters, SmallCapVoice, MissionIR, QualityStocks, Pennybuster, MarketBeat, Street Insider, Stock Stars, Stock Fortune Teller, smartOTC, PennyStocks24, CRWEWallStreet and CRWEFinance reported earlier on Gogoro Inc. (GGR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gogoro Inc. (NASDAQ: GGR) is a company involved in the manufacture of two-wheeled electric vehicles and battery swapping infrastructure.

The firm has its headquarters in Taoyuan City, Taiwan and was incorporated in 2011 by Matt Taylor and Horace Luke. It operates as part of the auto parts industry, under the consumer cyclical sector. The firm serves consumers in Taiwan.

The company is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. It is party to a strategic partnership with Foxconn Electronics Inc. The company’s solutions deliver smarter energy at scale, which helps its partners and communities at large to meet their critical carbon-reduction goals.

The enterprise’s two-wheeled electric scooters offer cloud connectivity and electric powertrain that uses swappable battery infrastructure for gathering, analyzing, and sharing riding data through a mobile application on the rider's smartphone. They include Gogoro S1, Gogoro SuperSport and 2 Series. Its battery swapping technology consists of an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which comprises of Gogoro Smart Batteries, Smartscooter, Gogoro Network Software & Battery Management Systems, GoStations and related components and kits.

The company recently entered into a strategic partnership with a leading electric vehicle-as-a-Service platform based in India, known as Zypp Electric. This move, which will involve launching a battery swapping B2B pilot in Delhi, will help extend the company’s global reach while also opening it up to new growth and investment opportunities.

Gogoro Inc. (GGR), closed Monday's trading session at $3.52, up 5.0746%, on 297,978 volume. The average volume for the last 3 months is 239,213 and the stock's 52-week low/high is $2.83/$17.59.

Paratek Pharmaceuticals (PRTK)

MarketBeat, StreetInsider, MarketClub Analysis, TraderPower, Schaeffer's, Barchart, StockMarketWatch, ProTrading Research, TradersPro, SmallCapVoice, AllPennyStocks, StreetAuthority Daily, Marketbeat.com, Streetwise Reports, InvestorsUnderground, FreeRealTime, The Street and QualityStocks reported earlier on Paratek Pharmaceuticals (PRTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Paratek Pharmaceuticals Inc. (NASDAQ: PRTK) (FRA: N4CN) is a commercial-stage biopharmaceutical firm that is focused on developing and commercializing life-saving treatments for life-threatening illnesses or other public health threats for military, government and civilian use.

The firm has its headquarters in Boston, Massachusetts and was incorporated in 1996 by Stuart B. Levy and Walter Gilbert. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is focused on making a difference in patients’ lives using its knowledge to manufacture drugs for ailments that aren’t responsive to treatments currently available. It is party to license agreements with Tufts University for the development of products to treat or prevent microbial or bacterial illnesses; and Tetraphase Pharmaceuticals Inc. for the development, import and sale of Xeravatm to treat complicated intra-abdominal infections caused by bacteria. In addition to this, the company is also party to license and collaboration agreements with Allergan Plc and Zai Lab Co. Ltd; and a contract with Biomedical Advanced Research and Development Authority to develop Nuzyra.

The enterprise’s product pipeline is comprised of a tetracycline designed for the treatment of moderate to severe acne vulgaris known as Seysara; and a once-daily oral and intravenous broad-spectrum antibiotic dubbed Nuzyra, which has been designed to treat patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens.

The firm, whose latest financial results show significant increases in its sales and revenues, remains focused on accelerating product demand and expanding its sales force. This will significantly grow its demand while bolstering its overall growth.

Paratek Pharmaceuticals (PRTK), closed Monday's trading session at $2.13, off by 6.5789%, on 239,338 volume. The average volume for the last 3 months is 207,878 and the stock's 52-week low/high is $1.60/$5.32.

Yalla Group (YALA)

MarketBeat, MarketClub Analysis, StreetInsider, Trades Of The Day, The Online Investor, Schaeffer's, InvestorPlace and Daily Trade Alert reported earlier on Yalla Group (YALA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Yalla Group Ltd (NYSE: YALA) (FRA: 80Q) is a holding firm which operates as a voice-centric social networking and entertainment platform engaged in the provision of software and communication solutions.

The firm has its headquarters in Dubai, the United Arab Emirates and was incorporated in 2018, on February 7th by XueCai Feng, Jian Feng Xu and Jin Tao Yang. Prior to its name change, the firm was known as FYXTech Corp. It operates as part of the software-application industry, under the technology sector. The firm primarily serves consumers in the North Africa and Middle East regions.

The company is focused on developing mobile applications which deliver seamless user experiences that foster a strong sense of belonging and create a loyal and highly devoted and engaged user community.

The enterprise’s offerings include its flagship mobile application, Yalla, which has been specifically tailored for the people and local cultures of the region. The application facilitates online voice-based chatting among users or voice live streaming through Yalla rooms. It also offers a casual board game platform dubbed Yalla Ludo, where individuals can play board games like Domino and Ludo. This is in addition to offering enhanced experiences for individual users via the provision of upgrade services on the platform and sale of virtual items.

The company recently announced its latest financial results, which show increases in its income and revenues. It is committed to improving its operational efficiency and expanding its user base, which will drive long-term growth and create significant shareholder value.

Yalla Group (YALA), closed Monday's trading session at $4.09, up 0.738916%, on 239,079 volume. The average volume for the last 3 months is 214,124 and the stock's 52-week low/high is $3.00/$10.40.

Praxis Precision Medicines (PRAX)

Schaeffer's, FreeRealTime, Trades Of The Day, MarketBeat and Daily Trade Alert reported earlier on Praxis Precision Medicines (PRAX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Praxis Precision Medicines Inc. (NASDAQ: PRAX) is a clinical-stage biopharmaceutical firm that is focused on the development of treatments for central nervous system disorders characterized by neuronal imbalance.

The firm has its headquarters in Boston, Massachusetts and was incorporated in 2015, on September 22nd by Steven Petrou, David Goldstein and Kiran Reddy. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United States.

The company is party to a collaboration with The Florey Institute, involving the development of 3 new antisense oligonucleotides (ASOs); a research collaboration, option, and license agreement with Ionis Pharmaceuticals Inc.; a license agreement with Purdue Neuroscience Company; and a cooperation and license agreement with RogCon Inc.

The enterprise’s product candidates include a selective small molecule inhibitor of T-type calcium channels dubbed PRAX-944, which is in Phase 2a trials for the treatment of essential tremors; and an extrasynaptic-preferring GABAA receptor positive allosteric modulator known as PRAX-114, which is undergoing phase 2a trials for the treatment of perimenopausal depression and major depressive disorder. It also develops an ASO dubbed PRAX-222 for patients with gain-of-function SCN2A epilepsy; and a persistent sodium current blocker known as PRAX-562, in Phase 1 trials to treat adult cephalgia and severe pediatric epilepsy.

The firm, which recently provided a corporate update, is committed to advancing research and trials for its PRAX-222 candidate for pediatric patients with epileptic encephalopathy. The success and approval of this formulation will not only benefit patients with this indication but also open the firm up to new growth and investment opportunities.

Praxis Precision Medicines (PRAX), closed Monday's trading session at $2.13, up 0.947867%, on 214,908 volume. The average volume for the last 3 months is 461,271 and the stock's 52-week low/high is $1.48/$20.85.

Image Protect (IMTL)

Small Cap Firm, Damn Good Penny Picks, Planet Penny Stocks, Buzz Stocks, Penny Picks, Profitable Trader Authority, Penny Stock Titans, Penny Stock General, PennyPickAlerts, Shiznit Stocks, Fortune Stock Alerts, MicroCapDaily, ProTrader, PennyStockScholar, Penny Stock 101, Penny Pick Finders, OTCtipReporter, MegaPennyStocks, PennyStockLocks, Stock Commander, StockRockandRoll, Epic Stock Picks, Wolf of Penny Stocks, BeatPennyStocks, StockOnion, Investor News Source, Winston Small Cap, InvestorPlace, Fast Money Alerts, BullFreak, Insider Financial, Beacon Equity Research, DSR News, InvestorSoup, Jet-Life Penny Stocks, OnPointStockAlert, AwesomeStocks, Penny Stock Finder, Penny Stock Mobsters, Penny Stock Prodigy, PennyStockProphet, PHUB News, POSstocks, SmallCapVoice, Stock Guru, Value Penny Stocks and Penny Stock Craze reported earlier on Image Protect (IMTL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Image Protect Inc. (OTC: IMTL) is a tech and media firm that is focused on microcap news, information and disclosure as well as crypto, blockchain, and digital assets.

The firm has its headquarters in New York, the United States and was incorporated in 1994 by Jonathan Thomas. It operates as part of the software-application industry, under the technology sector. The firm serves consumers in the United States.

The company uses artificial intelligence, image protect streamlines image registration, management, protection and distribution, enabling content creators to benefit from new revenue models and faster payments. It builds tools to allow images to be easily tracked and monetized across the web. The company operates through its wholly-owned subsidiaries, which include OTC PR Wire LLC, a revenue stage service provider and news platform that caters to microcap and small cap firms on an international scale.

The enterprise is focused on the monetization, protection and analysis of digital and visual content. Its offerings include a digital asset library and proprietary technology known as Fotofy.com, which helps the foundation of an impactful non-Fungible token (NFT) marketplace. The enterprise’s media properties include an auction site for NFTs of hip hop artists and sports figures known as www.legendsNFTS.io; and Tokentunz.com, a site developed for Music NFTs.

The company is focused on enhancing its business through the development of its NFT marketplace, which will create new revenue streams for the firm while also facilitating the creation of long-term value for its shareholders.

Image Protect (IMTL), closed Monday's trading session at $0.0003, off by 14.2857%, on 461,271 volume. The average volume for the last 3 months is 4.004M and the stock's 52-week low/high is $0.0002/$0.0013.

Canaan Inc. (CAN)

MarketClub Analysis, QualityStocks, Schaeffer's, InvestorPlace, TradersPro, StreetInsider, MarketBeat, Stockhouse, AllPennyStocks, INO Market Report, BUYINS.NET, InvestorsUnderground, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Canaan (NASDAQ: CAN), a leading high-performance computing solutions provider, is reporting its unaudited financial and operating results for the three-month period ended Sept. 30, 2022. Numbers of note from the report include computing power sold during the quarter totaling 3.5 million Thash/s, a 37.1% decrease from Q2 2022 and a 48.5% from 6.7 million Thash/s in the same period of 2021. CAN revenues reached $137.5 million, a decrease of 40.8% from the second quarter 2022 and a 25.8% decrease from the same period in 2021, with gross profit coming in at$32.9 million, net income totaling $8.6 million, and non-GAAP adjusted net reaching  $23.4 million. “The Bitcoin mining market deteriorated during the third quarter, as the Bitcoin price fluctuated and further dipped to around $16,000 recently,” said Canaan CEO and chair Nangeng Zhang in the press release.

“The negative market dynamics have significantly hindered Bitcoin miners’ revenues and cash flows. As miners are forced to cut their demand for computing power, we had to adjust down our selling price in response. As a result of contract sales that we secured from previous quarters and the delivery of these orders, our topline performance in the third quarter was within our expectations, with total computing power sold of 3.5 million Thash/s. In late November, we officially released our new mining machine series, AvalonMade 13. Powered by advanced ASIC technology on the next-generation process node, the new series product achieves prominently accelerated computing power and escalated power efficiency. The launch of the new generation product reaffirms our confidence in the fundamental value of the Bitcoin ecosystem and reflects our constant efforts in the research and development of supercomputing technology. Looking forward, we face a very tough industry period as the Bitcoin price is sinking to lows the market has not seen in two years. Our priority is to conserve our cash, minimize our expenses, and endure this market downturn. Without any interest-bearing debt, we will also remain prudent as we invest in key strategic areas such as research and development and wafer production capacity on advanced nodes.”

To view the full press release, visit https://ibn.fm/IqhNS

About Canaan Inc.

Canaan is a technology company focusing on ASIC high-performance computing chip design, chip research and development, computing equipment production, and software services. The company's vision states that “super computing is what we do, social enrichment is why we do it.” Canaan has rich experience in chip design and streamlined production in the ASIC field. In 2013, the company released and mass produced its first ASIC Bitcoin mining machine. In 2018, Canaan released the world’s first 7nm ASIC chip, providing energy-efficient computing equipment to the cryptocurrency mining industry. In the same year, Canaan released the world's first RISC-V architecture commercial-edge AI chip, further harnessing the potential of ASIC technology in the field of high-performance computing and artificial intelligence. For additional information about this company, visit www.Canaan.io.

Canaan Inc. (CAN), closed Monday's trading session at $2.96, up 10.0372%, on 4,003,661 volume. The average volume for the last 3 months is 939,271 and the stock's 52-week low/high is $2.46/$11.06.

Bit Digital Inc. (BTBT)

QualityStocks, MarketClub Analysis, StocksEarning, Schaeffer's, TradersPro, StockEarnings, MarketBeat, InvestorPlace and Daily Trade Alert reported earlier on Bit Digital Inc. (BTBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The New York Federal Reserve Bank has published a report detailing its findings from Project Cedar, an inaugural project geared at developing a technical framework through which a wholesale central bank digital currency (wCBDC) could be created for use by the Federal Reserve Bank.

During phase 1 of the project, the New York Fed wanted to demonstrate whether or not blockchain technology had the potential to improve access, increase speed and lower the costs associated with wholesale cross-border foreign exchange transactions. These transactions are very common because they are relied on by private banks, central banks and large corporations as well as other institutions that are domiciled in different jurisdictions in the execution of various transactions, including but not limited to international trade.

While transnational payment transactions currently work well, the New York Fed believes that there are opportunities for improvement, and the prototype designed in phase 1 of Project Cedar was aimed at looking for some avenues through which improvements could be effected in this space.

For example, it currently takes approximately two business days for a foreign exchange spot transaction to clear. In that time, the parties involved are exposed to a variety of risks, such as counterparty risks, settlement risks and credit risks. All these make it harder for the affected institution to access the liquidity it needs to keep functioning. Reducing the settlement time would therefore ease access to the needed liquidity and eliminate or at least reduce the risks of delaying to conclude a cross-border spot transaction.

During the test project, different simulated CBDCs were maintained on different blockchain ledgers as would be the case in the real world where no two central banks can run their monetary system using the same platform or protocol. The test project used Rust as the preferred programming language for the distributed ledgers.

The trial showed that FX spot transactions could be completed in a maximum of 15 seconds, both sides of a cross-border transaction were settled atomically (both sides approved or rejected a given transaction at the same time), and transactions were safer as well as more accessible since the system could operate 24/7 throughout the year.

The success of this phase of Project Cedar paves the way for the next phase, and the Federal Reserve Bank of New York says this next phase will look more closely at matters of interoperability, security and system design. Singapore’s Monetary Authority will be involved in this upcoming phase of the project.

This degree of involvement in blockchain tech by the NY Fed sends the right signals to the market, and other players such as Bit Digital Inc. (NASDAQ: BTBT) in the blockchain space will take encouragement from such high-level institutional interest in the space.

Bit Digital Inc. (BTBT), closed Monday's trading session at $1.14, up 3.6364%, on 939,271 volume. The average volume for the last 3 months is 227,585 and the stock's 52-week low/high is $0.94/$11.94.

Seelos Therapeutics Inc. (SEEL)

MarketBeat, StockMarketWatch, MarketClub Analysis, QualityStocks, TradersPro, Schaeffer's, BUYINS.NET, Trades Of The Day and INO Market Report reported earlier on Seelos Therapeutics Inc. (SEEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Sonoran desert toad is among the largest toads in continental North America. Measuring an average of seven inches, this species of toad is known to secrete an alkaloid on its skin that causes psychedelic-like effects when ingested.

Over the past few years, more and more people have begun taking part in a trend that involves licking the back of toads to achieve a psychedelic high. However, the alkaloid that produces these effects in humans is actually a toxin secreted by the toad to ward off predators.

On top of that, not all toads secrete this toxin; licking secretions from some toad species may cause adverse health effects and in some cases even death. Consequently, the National Park Service (NPS) recently warned visitors against licking what some call “psychedelic toads.”

Also referred to as the Colorado River toad, the Sonoran desert toad secretes psychedelics 5-MeO-DMT and DMT-derivative bufotenin. Although these compounds can be fatal when ingested by some animals, they produce psychedelic-like effects in humans.

Still, the NPS cautions, this doesn’t mean that handling toads is safe, stating that doing so could easily make you sick if the poison gets into your eyes. In some cases, some people choose to extract these alkaloids and vaporize them rather than licking them off the toads.

There is also another important factor at play here: the Sonoran desert toad is a threatened species in states where it is indigenous, such as California. Perhaps due to their psychedelic appeal, Sonoran river toad numbers have dropped dangerously low in recent years.

Early this year, wildlife experts implored the public to stop milking Colorado river toads for their alkaloids as they were in danger of completely dying out. In addition, University of Arizona Laboratory research associate and Tuscon Herpetology Society president Robert Antony Villa said that the toads are “susceptible to exploitation.”

With psychedelics currently experiencing a renaissance in both mainstream popularity and scientific research, plenty of people are looking to use them recreationally and medicinally. Studies have shown that these hallucinogenic drugs can have profound mental health benefits when paired with psychotherapy.

Millions of dollars are now being poured into psychedelic drugs, and several pharmaceutical companies such as Seelos Therapeutics Inc. (NASDAQ: SEEL) are looking to develop the next big psychedelic drug. In the meantime, however, psychedelics remain illegal at the federal level and in most states, leading to some people using questionable means to acquire them, such as licking toads.

While we wait for federal and state legislation to catch up with science, the National Park Service has one message for psychedelic enthusiasts: let the toads be.

Seelos Therapeutics Inc. (SEEL), closed Monday's trading session at $0.9402, up 0.021277%, on 227,585 volume. The average volume for the last 3 months is 4.754M and the stock's 52-week low/high is $0.4803/$2.18.

Fisker Inc. (FSR)

InvestorPlace, Schaeffer's, StocksEarning, MarketClub Analysis, MarketBeat, Kiplinger Today, The Street, QualityStocks, The Online Investor, Trades Of The Day, Daily Trade Alert, TradersPro, Early Bird, StreetInsider, TipRanks, wyatt research newsletter, Cabot Wealth, InvestorsUnderground and CNBC Breaking News reported earlier on Fisker Inc. (FSR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Almost 20 years ago, Tesla proved that electric vehicles could be manufactured for the mass market, and the company has enjoyed the benefits that come with being the first in an industry. Fast forward to today, the United States alone has recorded more than 400 companies looking to make and sell electric vehicles, and the competition is becoming stiff. In Italy, AEHRA, an EV startup isn’t fazed by all the existing and upcoming players in the electric vehicle space because it has an ace up its sleeve.

According to AEHRA CEO Hazim Nada, the company will bring freshness to EV design and infuse its vehicles with character, “an Italian-ness,” as he calls it. He says that the existing electric vehicles are designed through the lenses of conventional ICE vehicle design and that hangover of a bygone era makes the EVs boring. He wants to freshen up how electric vehicles are designed.

To this end, the ambitious CEO has hired Filippo Perini, formerly working with Lamborghini, to be the chief designer at the startup. Nada wants AEHRA’s vehicles to primarily focus on aerodynamics rather than on performance. He wants EVs with smoother lines and curves rather than the edges seen on nearly all cars on our roads. This isn’t just to provide eye candy, although that is also a major objective. Gentler curves boost aerodynamics and improve vehicle range. The vehicle interior will also be reimagined so that car occupants can be more comfortable.

Nada believes that his cars will gain traction on the market because younger car buyers aren’t constrained by the need to stick to a brand they have known for decades. Rather, they go for what they see as offering value. To Nada, there is a market for everyone, and he doesn’t see himself trying to grab a share from Tesla, Fisker Inc. (NYSE: FSR), Lamborghini or any other manufacturer. Coexistence is possible, he says.

AEHRA electric vehicles aren’t going to come cheap. With a planned production of a modest 20,000 to 25,000 units in 2025, the first models will be a sedan and an SUV, which will be priced at approximately $160,000 to a maximum of $180,000. These vehicles will first be launched in the United States and Europe before being rolled out to China and other markets.

Nada is famous for building the largest wind tunnel in the world, the AeroGravity. This Milan-based vertical tunnel enables visitors to have a firsthand taste of freefalling. He is bringing this passion for aerodynamics to the electric vehicle industry.

Fisker Inc. (FSR), closed Monday's trading session at $8.51, up 0.353774%, on 4,766,428 volume. The average volume for the last 3 months is 376,265 and the stock's 52-week low/high is $6.41/$23.75.

Royal Gold Inc. (RGLD)

TopStockAnalysts, Streetwise Reports, StreetAuthority Daily, InvestorPlace, TradingAuthority Daily, The Street, MarketBeat, Daily Wealth, Top Pros' Top Picks, StreetInsider, Daily Trade Alert, SmarTrend Newsletters, QualityStocks, TheStockAdvisor, All about trends, Energy and Capital, Zacks, Money Morning, MarketClub Analysis, The Growth Stock Wire, TheStockAdvisors, Trades Of The Day, Dividend Opportunities, Marketbeat.com, Wyatt Investment Research, Barchart, Wealth Daily, Uncommon Wisdom, Lebed.biz, Investor Update, Daily Profit, Schaeffer's, Investment U, Money and Markets, National Inflation Association, Stockhouse, The Online Investor, Traders For Cash Flow, TradingMarkets, Greenbackers, Forbes, Outsider Club, Kiplinger Today, Trade of the Week, Weekly Wizards, Market Intelligence Center Alert, Inside Investing Daily, Bourbon and Bayonets, BestChartNow, Wealth Insider Alert, AllPennyStocks, FNNO Newsletters, ChartAdvisor, GorillaTrades, Dynamic Wealth Report, One Hot Stock, INO.com Market Report, Investing Futures, The Best Newsletters, Investopedia, StocksEarning, Stocks That Move, Market Authority, Market FN, Stansberry Research, Short Term Wealth, Profits Run, PowerRatings Stocks, Penny Stock Chaser and Hit and Run Candle Sticks reported earlier on Royal Gold Inc. (RGLD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

With the cost of living increasing drastically and inflation at an all-time high, assets such as gold that have traditionally acted as stores of value should be in hot demand. Conventional wisdom says that markets should turn to gold at times like this as a hedge against inflation. However, gold has acted contrary to expectations in recent months, faltering amid inflation, an increasingly hawkish stance from the Fed and a surging dollar.

Gold prices went down by more than 1.5% in September, trading at as little as $1,643 per ounce and reaching a two-year low. OANDA senior analyst Edward Moya stated at the time that the increasingly valuable greenback was going to keep gold “vulnerable in the short term.”

Against conventional wisdom, gold prices have continually faltered at a time when they are expected to remain steady. With markets rushing to store their returns in gold, prices for the precious metal should be rising, but they have gone down by more than 7% over the past 12 months instead.

This is partly due to moves by the U.S. Federal Reserve to forestall inflation through tighter monetary policies. The Fed has raised the benchmark interest rate by 75 basis points for more than two consecutive months, increasing the opportunity cost of holding gold bullion and reducing its appeal to investors.

Central banks around the world have followed the U.S. Federal Reserve and increased interest rates in their respective countries to contain the ongoing inflation. Given that the global economy mostly runs on the dollar, high-interest rates have helped to increase the value of the greenback and reduced gold prices in tandem.

During the 2013 taper cycle, for instance, an 18% surge in the greenback’s value caused gold prices to go down by 16%. However, while the dollar rallied by 17% in last year’s cycle, the gap between the rise in dollar value and the drop in gold prices has been significantly less.

This is mostly because the economy wasn’t really dealing with any inflation during the last taper cycle, leading gold prices to act in accordance with conventional wisdom.

However, the global economy has faltered over the past couple of years, with Russia’s invasion of Ukraine earlier this year finally pushing things over the edge. Food and energy prices are at an all-time high, the cost of living is rising steadily, and experts predict that there will be a recession in 2023 and 2024.

If economic conditions remain as they are in this cycle, gold may not be regaining its status as a store of value any time soon, but miners such as Royal Gold Inc. (NASDAQ: RGLD) may not be too bothered by these periodic market movements since history shows gold will always bounce back.

Royal Gold Inc. (RGLD), closed Monday's trading session at $106.48, up 1.313%, on 377,040 volume. The average volume for the last 3 months is 288,367 and the stock's 52-week low/high is $84.54/$147.70.

The QualityStocks Company Corner

Vision Energy Corp. (OTCQB: VIHDD)

The QualityStocks Daily Newsletter would like to spotlight Vision Energy Corp. (OTCQB: VIHDD).

Vision Energy in November 2022 announced it had completed conceptuallayouts for its Green Energy Hub project in Vlissingen, theNetherlands

The company in September 2022 announced its commitment to anadditional 5.19 acres, expanding its Green Energy Hub projectfootprint to a total of 40.53 acres

Vision Energy is on schedule to file for the remaining constructionand environmental permits for its Green Energy Hub project byDecember 2022

Current hydrogen demand projections for northwest Europe outstripscheduled production for the next five to 10 years

Vision Energy Corp. (OTCQB: VIHDD) (“Vision Energy”) is a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sectors. Vision Energy is leveraging its team’s proven track-record in site and asset procurement, accelerating development and permitting processes, plant design, and grid integration to facilitate low-carbon energy production, supply and distribution. The company is pursuing reliable offtake relationships and operating partnerships with energy industry participants and end users seeking carbon abatements across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions with maximized yield, with projects designed to exploit existing gas and power infrastructure, to integrate and facilitate import and/or distribution of reduced-carbon energy to domestic and global supply chains.

The company believes that hydrogen and liquid carriers of hydrogen are the most reliable alternatives to fossil fuels. Hydrogen is anticipated by many energy analysts to become more widely competitive as an alternative mobile energy source as early as 2030, as economies of scale drive down costs.

According to the International Energy Agency report ‘Hydrogen in North-Western Europe (2021)’, the region is well placed to lead hydrogen adoption as a clean energy source. Today, this region comprises approximately 5% of global hydrogen demand and 60% of European demand. Moreover, the region is home to the largest industrial ports in Europe, where much of this hydrogen demand is located, and presents a well-developed natural gas infrastructure connecting these ports with other industrial hubs. This gas network could be partially repurposed to facilitate hydrogen delivery from production sites to demand centers. Governments in this region also have ambitious goals for greenhouse gas emissions reduction and there is strong political interest in hydrogen as a pathway to maintaining industrial activity in the region.

Vision Energy is based in Jersey City, New Jersey.

Projects

Through wholly owned subsidiary Evolution Terminals BV, Vision Energy is pioneering a Green Energy Hub development project for the import, storage and distribution of low-carbon renewable fuels and hydrogen carriers, strategically located in the North Sea port of Vlissingen at the mouth of the Westerschelde estuary in the Netherlands. This Green Energy Hub is positioned to be the first terminal in Europe focused on green and low-carbon energy products.

Vision Energy is at an advanced stage of planning for the construction of its Green Energy Hub and is on schedule to file for the remaining construction and environmental permits by December 2022. The Green Energy Hub design is capable of receiving seagoing vessels, barges and coasters, served by a dedicated deep-water jetty as well as rail and truck loading infrastructure that will enable direct access to purpose-built storage and handling facilities for low-carbon fuels and hydrogen carriers, including ammonia, methanol and liquid organics. Phase 1 capital expense is estimated at approximately €450 million, including jetty infrastructure, and will provide for up to 400,000 cubic meters (CBM) of storage capacity with land already secured for future expansion.

Market Opportunity

In Northwestern Europe, the market for green hydrogen, or hydrogen produced by renewable energy, is growing rapidly. The current hydrogen demand projections outstrip the scheduled production for the next five to 10 years.

The company believes that all producers will face high demand. Moving beyond its initial Green Energy Hub, Vision Energy is focused on countries where governments support a regulatory standard that promotes hydrogen production and consumption. Many governments have established various incentives and financial mechanisms to accelerate and promote the use of hydrogen as a renewable energy source.

The EU, through its European Green Deal, has set an objective to become climate-neutral by 2050, implying the near total phase-out of fossil fuels in the EU energy system, and many countries are working to put in place subsidy programs for the development of green hydrogen facilities in anticipation of this goal.

Vision Energy projects its total addressable market at €10 billion by 2050.

Management Team

Andrew Hromyk is CEO of Vision Energy. He has supported and operated chemical and energy operations in the Permian Basin, central and south Texas, Arkansas, Alberta and internationally. An active investor, he has been involved with companies developing a diverse range of technologies, from enhanced and conventional hydrocarbon recovery processes to wireless infrastructure. He has participated in numerous industrial and commercial real estate developments. He also has served as a director of several private companies that became publicly traded on Nasdaq, NYSE and TSX. He studied economics at Chaminade University and the University of British Columbia.

Arron Smyth is Executive Vice President of Corporate Development at Vision Energy. He has more than 18 years of experience in financial services, investment banking, business leadership and operations in both developed and emerging markets. Since 2018, he has been Managing Director Europe for the First Finance group of companies, developing and supporting the group’s private equity investments and projects, including Evolution Terminals, the Netherlands-based developer of tank terminal and port infrastructure for the bulk storage and handling of clean and sustainable energy products.

Matthew Hidalgo is CFO of Vision Energy. He has over 15 years of experience in accounting, operations, finance, corporate restructuring and integrating acquisitions. He is a Managing Partner at Turquino Equity LLC, a private equity investment firm. Formerly, he was the controller and operations manager for the largest subsidiary of WPCS International Incorporated, managing over $30 million in annual revenue. Prior roles included managing accounting functions for several Australian subsidiaries. After graduating from Penn State with a bachelor’s degree in accounting, he began his career at PricewaterhouseCoopers.

Vision Energy Corp. (OTCQB: VIHDD), closed Monday's trading session at $17.8, up 10.559%, on 288,377 volume. The average volume for the last 3 months is 30,943 and the stock's 52-week low/high is $1.25/$18.20.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources Ltd. Owns a 98% interest in Minera Tupiza with anoption to acquire 99% interest in a neighboring highly soughtafter, royalty-free property in southern Bolivia

Eloro has an option to acquire a 99% interest in the 9 square km,highly prospective Iska Iska Property, which hosts a majorsilver-tin polymetallic porphyry-epithermal complex located 4,000mabove sea level

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a publicly traded exploration and mine development company,established in 1985 with a portfolio of gold and base-metalproperties in Bolivia, Peru and Quebec.

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.

Projects

Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Monday's trading session at $2.3465, up 0.449486%, on 33,943 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $18.20/$.

Recent News

Tingo Inc. (OTCQB: TMNA)

The QualityStocks Daily Newsletter would like to spotlight Tingo Inc. (TMNA).

Tingo (OTC: TMNA) today announced that it has filed its quarterly report on Form10-Q, wherein the company reported its financial results for thethree and nine months ended Sept. 30, 2022. Among the highlights,the company reported growth in its Nwassa agri-fintech businessthat has driven increases of 64.8 % in revenues and 53.9 % inoperating profit as compared to Q3 2021. In addition, the companyreported that it has filed a definitive Information Statement onSchedule 14C, marking a major milestone towards completion of themerger of Tingo Mobile PLC, the company’s sole operating subsidiary(“Tingo Mobile”), with MICT Inc. (NASDAQ: MICT), a Nasdaq-traded financial technology firm. MICT also announcedits operating results for the third quarter of 2022, whichreflected a 15% increase in quarter-over-quarter revenue, as wellas a 54% quarter-over-quarter increase and 16% year-over-yearincrease in gross profit.

Tingo Inc. (OTCQB: TMNA) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (ACFT) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.

Businesses

Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created Africaprepay.com, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (FDI) in the financial services sector and facilitate greater public/private cooperation.

Tingo Inc. (OTCQB: TMNA), closed Monday's trading session at $1.18, up 34.0909%, on 26,765 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.01/$6.00.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

In June 2020, CNS’ lead drug candidate, Berubicin, received OrphanDrug designation from the FDA. In June 2021, it received Fast Trackdesignation following positive results from an extensive clinicalstudy that saw 44% of the patients post a clinical response, withone Durable Complete Response

With GBM having a survival rate of only 6.8% and an average lengthof survival of only eight months, Berubicin is showing tremendouspotential, and CNS is leading the charge to find a potentialtreatment option for the disease

CNS’ management is optimistic about its lead drug candidate andcontinues to explore the potential treatment of other conditionssuch as lymphomas, lung and breast cancers

Even though there are several treatments that can be used to fightcancer and prolong a cancer patient’s life, the disease has no cure. For the longest time, scientists have been trying to findtreatments that could completely eradicate cancer cells without theside effects typically associated with conventional cancer treatments, but no successhas been registered.Recent research from the University of Basel has revealed thatabnormal cancer cells specifically use sugar molecules on their surface to defend themselves against the immune system.According to University of Basel researchers, this mechanismcan nullify this mechanism and make cancer cells much moresusceptible to attacks from the immune system. Läubli noted thatthe next step is to find a way to successfully remove sialic sugarsfrom cancer cells and their surroundings, with minimum sideeffects. The segment of organ-specific cancer treatments is alsobeing advanced by companies that are developing drugs specificallytailored to treat brain cancers, such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Monday's trading session at $0.1944, up 2.8571%, on 93,494 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.16/$1.48.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

  • Coyuchi is currently accepting investments under its RegulationA+ offering and is approaching the $1 million milestone
  • KingsCrowd has published a review on Coyuchi, highlighting thecompany’s strengths and future industry challenges to be met
  • The report discusses how few individuals are better suited torun a sustainable company than CEO Eileen Mockus, given herbackground in working in the sustainable fabrics industry
  • Research shows that more consumers are drawn to products thatoffer sustainability, and will pay more for those products overname brands

Coyuchi, an organic luxury bed, bath, and apparel company setting the goldstandard for sustainably produced luxury home goods, is pleased toannounce that KingsCrowd, an investor analyst news publication forstartup investing, has published a review on the company. Thereport focuses on Coyuchi’s strengths and the journey necessary forthe company to reach unicorn status to provide decent returns toits investors under its Regulation A+ offering.

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values (https://ibn.fm/PANNV). With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through coyuchi.com), creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News

chart

Correlate Infrastructure Partners Inc. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Infrastructure Partners Inc. (OTCQB: CIPI).

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform fordistributed energy solutions across North America, has announcedfinancial results for the third quarter ended Sept. 30, 2022, andyear-to-date ended Sept. 30, 2022. Among the highlights, thecompany reported $2,312,577 in total revenue for the three monthsended Sept. 30, 2022, compared to $236,690 for the three-monthperiod ended June 30, 2022. The significant increase resulted fromcompletion of construction milestones in contracted projects. “Wecontinue to make smart choices to optimize our organic projectdelivery based on a dynamic 2022 regulatory and supply chainlandscape. The Inflation Reduction Act enacted in late Augustprovided new tax incentives that reduce costs for clients and/orelevate returns to investors; this led to larger contract sizeswith redesigns to domestic content. While this meant delaying someproject starts, it will be a big net gain, and will open newmarkets for us in 2023,” said Todd Michaels, chief executiveofficer of Correlate. “With this in mind, we have finalized ourM&A plans through Q2 2023 and seek to close our firstacquisition by year end.” To view the full press release, visit https://ibn.fm/Y75kU

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment solutions for the commercial real estate industry. The company believes scaling distributed clean energy solutions is critical in mitigating the effects of climate change. CIPI is at the forefront in creating an industry-leading energy solution and financing platform for the commercial and industrial sector. The company sees tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale.

The opportunity exists to remove friction between today’s legacy finance process and the needed clean-energy upgrades developed within the company’s program technologies. For the U.S. to reach its 2050 carbon goals, 200,000 commercial buildings must be retrofitted every year until that date. That represents approximately a 5-10x increase over the 2022 industry process run rate.

CIPI announced completion of its acquisition of 100% of the equity of Correlate Inc. and Loyal Enterprises LLC dba Solar Site Design on December 28, 2021. The company notes these acquisitions occurred at a key inflection point of its growth. CIPI currently enjoys channel and sales partnerships with Fortune 250 companies and a strong, proven industry network.

The company’s transparent, leading-edge model changes value delivery for both facility owners and proven solution providers seeking scale. CIPI believes its rapid growth is due to industry demand for actionable, cashflow positive energy programs and the underlying carbon reduction mandates taking effect globally.

CIPI has filed with the SEC for a name change to Correlate Infrastructure Partners Inc., which will more closely reflect its new platform and growth focus. The company has been aggressively moving to rebrand, with efforts including a revised website, investor presentation materials and an investor relations awareness campaign. The company’s shares will continue to trade on the OTCQB Venture Market under the current ‘CIPI’ ticker symbol until changes are approved.

Subsidiaries

Correlate, founded in 2015, is a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions focused on locally-sited solar, energy storage, EV infrastructure, and intelligent efficiency measures. Its unique data-driven approach is powered by proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network to help building owners profit from fully funded, turnkey decarbonization and facility health programs. The platform is designed for commercial and industrial real estate owners seeking to significantly improve net operating income while meeting carbon reduction goals. The platform provides energy programs for commercial property portfolios and requires no upfront capital. Client organizations reduce their risk and generate more profits by leveraging Correlate’s unique payment programs to put more cash in the bank. Deploying Correlate’s strategic energy programs and energy management systems allows property-owning organizations to complete big energy changes across their portfolios.

Solar Site Design, founded in 2013, is a U.S. Department of Energy Sunshot Catalyst winner that provides customer acquisition and project development tools for the commercial solar industry. Its commercial marketplace platform connects highly qualified project opportunities to leading solar construction companies nationwide. The Solar Site Design platform gives commercial and industrial property owners access to the best price for a commercial solar system. Commercial solar analysts provide property owners a site assessment and working project proposal. Solar Site Design’s team of solar engineers finalize the design while approved financing providers help clients explore financing options for their projects. Then, approved contractors in Solar Site Design’s Marketplace bid on the projects, ensuring commercial and industrial property owners get the best estimates for their projects. Solar Site Design’s marketplace process promotes transparency and fair pricing. Its team of experts has nearly 20 years of experience in the solar industry. Only reputable, experienced, certified (NABCEP), licensed, bonded and insured contractors are accepted into the Solar Site Design Marketplace.

Market Outlook

CIPI is in a rapidly growing market with a unique offering to address a total market of more than 5.9 million commercial buildings in the United States, according to the U.S. Energy Information Administration. Currently, the company’s wholly owned subsidiaries, Correlate and the Solar Site Design, have an opportunity pipeline of over $100 million in commercial projects with more than $20 million in awarded backlog. According to the Rocky Mountain Institute, portfolio energy optimization is a $290 billion market in the United States driving deep financial savings and energy efficiency across the commercial sector.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon, and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings. Yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which has very different needs than traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue known as the “split incentive”, unlocking the majority of the addressable market.

Management Team

CIPI has in place a nationally recognized management team that has been active in the energy market since 2005.

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

David Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jason Loyet is VP of Commercial Sales of Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Deke Welling is Head of Project Development and Fulfillment Services at Correlate Inc. He has over 19 years’ experience in the energy industry with an emphasis on renewables and energy efficiency over the past seven years. Prior to entering the renewables sector, Mr. Welling was the CEO of Welling Resources, an energy development company focused on the exploration of oil and natural gas reserves in the U.S. It was this experience that led him into the renewables sector and leading a charge for more sustainable resources. Additionally, Mr. Welling also served as the CEO of Circle L Solar Inc., a top 100 solar installer in the United States since 2016. Through his leadership, Circle L Solar experienced a growth rate of over 2,250% from 2016 to 2019, resulting in his company being listed on the Inc. 5000 list of the fastest growing private companies in the U.S. (Rank #176) and being named ‘Top Energy Company’ and ‘Entrepreneur of Year for the Energy Industry’ by the American Business Awards® in 2019 and again for ‘Entrepreneur of the Year’ in 2021.

Kevin Warren is Head of Construction and Development Engineering at Correlate Inc. He is a solar veteran with over 12 years of experience in the field. Prior to co-founding CLS, Mr. Warren was the owner of Beacon Consulting and has originated, consulted, designed and/or engineered over 122 MW of PV installations ranging from small commercial to utility scale projects throughout Texas, California, Colorado and North Carolina. He holds a Photovoltaic Technical Sales Professional Certification from the North American Board of Certified Energy Practitioners and certifications from Solar Energy International in PV Installation, PV Technical Sales, PV battery-based design, PV design and engineering, and PV operations and maintenance. Along with PV expertise, Mr. Warren is a LEED Green Building Associate, a certified building analyst from the Building Performance Institute, a Certified Renewable Energy Professional from the Association of Energy Engineers and holds a designation in High-Performance Sustainable Buildings from the BOMI Institute. He studied Electrical Engineering at the University of Texas at Arlington.

Tom Kunhardt is Director of Customer Success at Correlate. He previously held a similar position at Clean.Tech and was Corporate Trainer, Learning & Development, at NRG Energy. He has 15 years of experience in the solar and clean energy industries helping homeowners and businesses find solutions to their energy needs. He holds a bachelor’s degree from the University of Massachusetts.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), closed Monday's trading session at $1.57, even for the day, on 29 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.32/$3.25.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements(“REE”), today announced its entry into a definitive agreement tosell three wholly owned subsidiaries that together hold its AltaMesa ISR Project to enCore Energy for total consideration of $120million (the “transaction”). The transaction, which is expected toclose by the end of 2022 or early 2023, is significant for thecompany, as the cash received is expected to fully finance much ofEnergy Fuels’ uranium, REE, vanadium and medical isotope businessplans for the next two to three years without dilutingshareholders. “This is a unique transaction for Energy Fuels. Notonly does it allow us to monetize the Alta Mesa Project for $120million, it allows our company to focus and accelerate our higherpriority uranium and rare earth projects without dilution to ourshareholders,” said Mark S. Chalmers, president and CEO of EnergyFuels. “This non-dilutive transaction will add cash to EnergyFuels’ significant working capital position, which was $122 millionat September 30, 2022. Energy Fuels will also retain some exposureto short-term market upside and optionality at Alta Mesa and enCorethrough the convertible note.” To view the full press release,visit https://ibn.fm/QF8r3

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Monday's trading session at $7.52, off by 2.3377%, on 2,324,955 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.69/$11.14.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rarecannabinoids, has reported its financial results for the firstquarter of fiscal year 2023, ended Sept. 30, 2022. Highlights ofthe report included updates on the company’s pharmaceuticaldevelopment programs, including INM-755 for the treatment ofepidermolysis bullosa (“EB”) and INM-088 for the treatment ofglaucoma. According to the report, enrollment and patient treatmentin the company’s phase 2 clinical trial for INM-755 should becomplete by the end of the year while the company continues toconduct key preclinical work including toxicology and GLP studiesin advance of human clinical trials for INM-088. InMed is advancingdiscovery work to identify an appropriate compound for itspreclinical development program targeting treatment forneurodegenerative disorders such as Alzheimer’s disease,Parkinson’s disease and Huntington’s disease. To view the fullpress release, visit https://ibn.fm/UK7Jx

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Monday's trading session at $2.78, off by 7.3333%, on 68,324 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.40/$59.25.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”),continues to sign contracts and agreements as it delivers on itsmission to provide safety and security to a growing number oforganizations around the country. Most recently, Knightscope hassigned a contract with a New Jersey university to deliver 31 K1Blue Light Towers and 10 K1 Blue Light E-Phones. The new contractshows the rising interest that college campuses are showing inKnightscope services. According to the announcement, college safetyis a major priority for students when they select which institutionto attend. Consequently, colleges and universities are looking forways to strengthen and support their security systems. To view thefull press release, visit https://ibn.fm/ofpsX

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at www.knightscope.com/crime

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at www.knightscope.com/investors

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at www.knightscope.com/ksoc

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at www.knightscope.com/roadshow

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Monday's trading session at $2.67, off by 1.476%, on 234,997 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.3001/$27.50.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’srenewable natural gas (“RNG”) infrastructure platform, appears tohave a strong position to expedite growth as it remains committedto delivering on its ambitious goals for a more sustainable future.“EverGen Infrastructure has announced that its wholly ownedsubsidiary Fraser Valley Biogas Ltd. (‘FVB’) has signed a termsheet for a long-term RNG offtake agreement intended to replace theexisting agreement as it approaches the end of the term. As a legalcontract in which a buyer agrees to purchase a certain amount ofthe product at set price points, offtakes are an essential tool forproducers to secure a predictable revenue stream for the projectand improve access to funding,” explains a recent article. “Theterm sheet for the new deal, expected to cover the purchase of upto 190,000 gigajoules of RNG annually from FVB, is penned amidconsiderably stronger market pricing compared to when the facilityinitially started. This milestone supports full funding ofEverGen’s Core RNG expansion project at FVB and marks an importantstep towards the company’s goal of 1,000,000 GJ of RNG per yearfrom its core RNG expansion and development project portfolio.” Toview the full article, visit https://ibn.fm/pSbuD

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Monday's trading session at $1.6, off by 0.928793%, on 2,500 volume. The average volume for the last 3 months is 2,500 and the stock's 52-week low/high is $1.365/$4.21.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

As more states legalize cannabis, residents of senior livingcommunities are using the substance more and more, and this isputting the operators of those facilities in the spotlightregarding how they respond to this reality. At the moment, marijuana is categorized as a schedule 1substance, the same category as heroin, MDMA, LSD and cocaine.While President Joseph Biden instructed the attorney general andthe health and human services department to review thiscategorization, the law is the law, and marijuana users are stillregarded as criminals. Public opinion has changed sharply on thismatter, and pressure is mounting to allow cannabis to be usedmedically and recreationally. The executive order mandating thereview of marijuana’s status in the Controlled Substances Act isone of the many steps and processes that may need to be performedbefore any changes can be made. The United States Drug EnforcementAdministration (DEA) is likely to have a big say in anyrecommendations made at the conclusion of the review and how thoserecommendations are to be implemented. It may be several yearsbefore senior living communities and companies with interest in themarijuana industry, such as Advanced Container Technologies Inc. (OTC: ACTX), have a clear answer as to what policy direction is likely toemerge from the review process.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in November 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Monday's trading session at $0.45, off by 18.1669%, on 746 volume. The average volume for the last 3 months is 746 and the stock's 52-week low/high is $0.2005/$1.87.

Recent News

Odyssey Group International Inc. (OTC: ODYY)

The QualityStocks Daily Newsletter would like to spotlight Odyssey Group International Inc. (OTC: ODYY).

Odyssey filed for US and global patent protection on its novelbreath-propelled, intranasal brain-drug delivery device thateffectively deposits concentrated drug deep into the nasal cavityfor the treatment of CNS injury disease or disorder

The application follows the successful completion of the secondCohort of Odyssey’s Phase I MAD clinical trial, which saw theeffective use of the device and a proven safety profile for thecompany’s concussion pharmaceutical treatment

Michael Redmond, the company’s CEO, has expressed the company’spleasure in the functionality of the device, citing how it providesa significant opportunity and advantage for the treatment ofneurological conditions

The patent application bolsters Odyssey’s growing list of medicaldevices, which currently comprise a CardioMap, a heart monitoringand screening device, as well as Save-A-Life, a handheld chokingrescue device

Odyssey Health (OTC: ODYY), a medical enterprise focused on unique, life-saving medicalproducts that offer clinical advantages to unmet clinical needs,just announced filing for the United States and global patentprotection on its novel breath-propelled, intranasal brain-drugdelivery device. This comes on the heels of the successfulcompletion of the second Cohort of its Phase I Multi-Day AscendingDosing (“MAD”) clinical trial, which saw the successful use of thedevice, and a proven safety profile of the company’s concussionpharmaceutical treatment.

Odyssey Group International Inc. (OTC: ODYY) is a medical technology company focused on developing lifesaving medical products that offer technological and clinical advantages over current standards of care.

The company’s portfolio of product technologies is diverse, featuring four unique medical products in development. Odyssey’s goal is to deliver superior products with enhanced clinical utility and market potential, thereby yielding a high rate of return for its shareholders and partners. It is guided by a senior management team with significant experience relating to refining technologies, building commercial systems and forging strategic partnerships.

Product Portfolio

Pharmaceuticals

Odyssey has two pharmaceutical products in development:

  • PRV-002 is a novel compound for the treatment of concussion, which currently has no FDA-approved drug. In pre-clinical studies, PRV-002 has been shown to significantly improve both neuroscore and memory score following injury in rats subjected to concussion models. Importantly, the first-in-class novel neurosteroid demonstrated no drug-related toxicity in these trials.
    • PRV-002 is currently being evaluated in a phase I clinical trial for the treatment of concussion, with phase II trials planned for launch in Fall 2022. Odyssey has also highlighted the potential of PRV-002 for additional indications such as Alzheimer’s disease, Parkinson’s disease, ALS and chromic traumatic encephalopathy (CTE).
  • PRV-001 is a novel compound intended to treat Niemann-Pick disease, a rare neurodegenerative-lysosomal storage disorder that affects an estimated 1 in 150,000 individuals in the U.S., demonstrating a 5x higher incidence in Middle Eastern populations.
    • Odyssey expects to receive Orphan Drug designation from the FDA for PRV-001, which would accelerate its pathway to FDA approval and provide seven years of market exclusivity.

Medical Devices

Odyssey is also developing two medical device candidates:

  • CardioMap® is intended to provide early, non-invasive testing for heart disease. The system offers a number of potential advantages over traditional EKGs, including requiring less training to operate, offering heightened sensitivity and coming in a small and portable form factor. CardioMap is being developed for a 510(k) regulatory pathway, which requires a study to demonstrate equivalence to legacy EKG offerings.
    • When approved, CardioMap is expected to be the only device in its class that has a predictive value, illustrating ‘grey’ areas where deterioration has begun but not yet led to pathology. Odyssey expects this feature to provide a powerful incentive for doctors to use the CardioMap device in end markets such as hospitals, doctors’ offices, rehabilitation centers and sports medicine practices.
  • Save-A-Life (SAL) is a patented, single-action, instantaneous, handheld, mechanical anti-choking device that creates a vacuum chamber in the mouth to dislodge throat obstructions in a matter of seconds, all without harm to the victim. The device is currently in development, with a proof of concept established.
    • Odyssey believes that, once FDA-approved, its anti-choking device will quickly become the “accepted” standard and leader in the treatment of choking incidents globally. Its low-cost manufacturing and convenient portable design give SAL a competitive edge over competing devices utilizing cumbersome masks.

Market Opportunities

Odyssey’s varied development pipeline positions it to address a number of sizable market opportunities with significant unmet medical need. Concussions alone currently account for medical costs of roughly $10-15 billion annually in the U.S., despite the lack of a currently approved FDA drug treatment. This need is particularly apparent in the military and sports industry, where the likelihood of athlete head-injury recurrence is estimated at 75%.

It is for this reason that, in March 2021, Odyssey announced the formation of a sports advisory board featuring well-known athletes supporting the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-approved therapy. Members of Odyssey’s sports advisory board include NFL Hall of Famers Kurt Warner & Brett Favre and two-time Olympic gold medalist Abby Wambach.

With its CardioMap platform, Odyssey is targeting the global cardiac monitoring market, which was valued at $28 billion in 2021 by Insight Partners and forecast to reach $43 billion by 2028.

Save-A-Life targets a similarly underserved market. Choking is the fourth-leading cause of death in children, and approximately 5,000 choking deaths occur each year in the U.S. While 95% of these deaths result from in-home incidents, current choking rescue devices fail to address in-home applications.

Management Team

Joseph Michael Redmond is the President, CEO and Chairman of Odyssey. He has over 30 years of commercial experience in medical device companies, previously serving as CEO of Parallax Health Sciences Inc., V.P. of Business Development for DxTech Inc. and V.P. of Sales and Marketing for Bioject Medical Technologies Inc. While at Bioject, Mr. Redmond helped raise over $15 million in capital, entered into several licensing and distribution deals with major biotech and pharmaceutical companies and grew the market cap of the company from under $10 million to over $400 million. He started his career at Abbott Labs and holds a B.A. from Denison University.

Christine M. Farrell is the company’s CFO and Secretary. Prior to joining Odyssey, Ms. Farrell was Vice President of Finance for Bioject Medical Technologies Inc. She also held accounting and financial management positions with Spar-Tek Industries, a manufacturer of high quality and cutting-edge technology for the plywood industry, and Action Machinery, a seller of new and used robotic machine tools and equipment. Ms. Farrell holds a B.A. in Accounting from the University of Washington and an M.B.A. from Willamette University.

Dr. Jacob W. Vanlandingham is Odyssey’s Head of Drug Development. Dr. Vanlandingham holds a Ph.D. in neuroscience with a molecular biology focus. He is a member of the Society for Neuroscience, American Society for Nutritional Sciences, National Neurotrauma Society, Faculty for Undergraduate Research in Neuroscience and the International Association of Medical Science Educators.

Odyssey Group International Inc. (OTC: ODYY), closed Monday's trading session at $0.201, off by 12.5326%, on 120,265 volume. The average volume for the last 3 months is 120,265 and the stock's 52-week low/high is $0.11/$0.64.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.